Citation Impact
Citing Papers
2017 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity
2012
DNA methylation age of human tissues and cell types
2013 Standout
Thromboprophylaxis in the Cancer Patient
2001
The risk of venous thromboembolism is increased throughout the course of malignant glioma
2000
Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability
2008
Update on the management of familial central nervous system tumor syndromes
2007
On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak
2003
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
2012
The WHO Classification of Tumors of the Nervous System
2002 Standout
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
2006 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Molecular subgroups of medulloblastoma
2012
Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center
2011
Cushing's syndrome
2015 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Thromboembolic disease in patients with high-grade glioma
2012
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features
2001
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Histopathologic grading of medulloblastomas
2002
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
2011 Standout
Parietal and Occipital Lobe Epilepsy: A Review
1993
Prevention of VTE in Nonsurgical Patients
2012 Standout
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Prevalence of Muscular Dystrophies: A Systematic Literature Review
2014 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Central Nervous System Aspergillosis
2012
Morphophenotypic Variation Predicts Clinical Behavior in Childhood Non-Desmoplastic Medulloblastomas
2003
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine
2005
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Medical management of patients with brain tumors
2006
Malignant Gliomas in Adults
2008 Standout
Histological variants of medulloblastoma are the most powerful clinical prognostic indicators
2012
Prevention of Venous Thromboembolism
2004 Standout
The changing face of acromegaly—advances in diagnosis and treatment
2012
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
2008
PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
2010
Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome
2007
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Evaluation of magnetic resonance angiography with selective maximum intensity projection in patients with childhood moyamoya disease
1998
Prevention of Venous Thromboembolism
2008 Standout
Primary brain tumours in adults
2012 Standout
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
2011
A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression
2013
Identification of human brain tumour initiating cells
2004 StandoutNature
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Thromboembolism in brain tumors
2001
Nodule Formation and Desmoplasia in Medulloblastomas—Defining the Nodular/Desmoplastic Variant and Its Biological Behavior
2007
Venous thromboembolism and survival in patients with high-grade glioma
2007
A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme
2000
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 Standout
Approach to the Patient with Possible Cushing’s Syndrome
2009
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
2009
Monogenic Vessel Diseases Related to Ischemic Stroke: A Clinical Approach
2007
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Moyamoya following cranial irradiation for primary brain tumors in children
2007
Chorea: an unusual presenting feature in pediatric Moyamoya disease.
2000
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Ischemic Stroke in Young Patients With Activated Protein C Resistance
1995
MR Angiography of Moyamoya Disease Before and After Encephaloduroarteriosynangiosis
2000
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
2007
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Stroke In Children
1996
Impaired decision‐making and selective cortical frontal thinning in Cushing's syndrome
2014
MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
2008
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
2008 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
The Origins of Medulloblastoma Subtypes
2008
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
High Frequency of Germline SUFU Mutations in Children With Desmoplastic/Nodular Medulloblastoma Younger Than 3 Years of Age
2012
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of C. Carollo being referenced
Pontocerebellar Angle Aspergillosis
2011
Volumetric MRI analysis of hippocampal subregions in Cushing's disease: A model for glucocorticoid neural modulation
2010
Clinical and neuroradiological findings of Moyamoya disease in Italy
1997
Childhood stroke associated with familial protein S deficiency
1994
Magnetic resonance angiography in moyamoya disease
1995
The usefulness of combined biochemical tests in the diagnosis of Cushing’s disease with negative pituitary magnetic resonance imaging
2007
Increased Rate of Intracranial Saccular Aneurysms in Acromegaly: An MR Angiography Study and Review of the Literature
2011
Medulloblastoma with extensive nodularity: a variant with favorable prognosis
1999
Reduced right posterior hippocampal volume in women with recurrent familial pure depressive disorder
2010
An unusual cystic appearance of disseminated low-grade gliomas
2001
Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study
1997
Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme
1998
Spontaneous Partial Regression of Low-Grade Glioma in Children With Neurofibromatosis-1: A Real Possibility
1999
Congenital muscular dystrophy: brain alterations in an unselected series of Western patients.
1991
Bilateral Cerebral Occipital Calcifications and Migraine-Like Headache
1987